Who Should Get a Carotid Ultrasound? The Risk Factors That Matter

If you have two or more cardiovascular risk factors, a carotid ultrasound can detect plaque buildup in your neck arteries before it causes a stroke. Stroke is the fifth leading cause of death in the United States and a leading cause of long-term disability, according to the American Stroke Association (2024). Yet most people with significant carotid disease have no symptoms at all until an event occurs. The scan takes about 30 minutes and requires no preparation. This article walks through exactly who benefits from it and why.

Who Should Get a Carotid Ultrasound?

Adults with two or more cardiovascular risk factors are appropriate candidates for targeted carotid ultrasound screening. According to the Society for Vascular Ultrasound (SVU, 2022), the cumulative burden of risk factors substantially raises the probability of finding clinically meaningful carotid disease. A single baseline scan establishes whether atherosclerotic plaque is already present. That information changes clinical decisions in a way that no blood test or symptom inventory can replicate.

The distinction between "symptomatic" and "asymptomatic" carotid disease is worth understanding. Symptomatic disease means you've had a transient ischemic attack (TIA) or stroke and carotid stenosis is the suspected cause. In that context, imaging is urgent and non-negotiable. Asymptomatic disease is what this article focuses on: plaque and stenosis present in someone who feels completely normal. That's the window where screening actually saves lives.

The American Heart Association (2021) estimates that approximately 2 million Americans have asymptomatic carotid artery stenosis of 50% or greater. Most don't know it. The standard clinical exam, including listening with a stethoscope for a carotid bruit, misses a significant proportion of cases. Ultrasound is the definitive non-invasive tool. Learn more about stroke risk and how the carotid arteries are involved.

What Does the USPSTF Actually Say - and What It Doesn't?

The U.S. Preventive Services Task Force (USPSTF, 2021) gave a Grade D recommendation against screening for asymptomatic carotid artery stenosis in the general adult population. That's the recommendation people cite when they say carotid ultrasound screening isn't recommended. It's also the one most frequently misapplied. The USPSTF Grade D applies specifically to unselected, low-risk populations with no relevant risk factors. It does not apply to individuals with hypertension, diabetes, smoking history, prior TIA, or multiple compounding risk factors.

The task force's concern with mass screening is straightforward. In a truly low-risk population, the rate of finding significant stenosis is low. A positive finding may lead to carotid endarterectomy, which carries its own procedural risk. When pre-test probability is low, the risk-benefit calculation doesn't favor mass screening. That math changes completely in high-risk patients, where plaque prevalence is meaningfully higher and early detection enables meaningful intervention.

Multiple professional societies take a different position on targeted screening. The American College of Cardiology and American Heart Association (AHA/ACC, 2022) both recognize carotid duplex as a reasonable screening tool in patients with risk factors for atherosclerotic disease. The Society for Vascular Surgery supports imaging in patients with clinical risk factors. The clinical community's consensus is that population-level and individual-level recommendations are not the same question.

The Carotid Ultrasound Risk Factor Checklist

Review the eight risk factors below. Each one independently raises your likelihood of carotid atherosclerosis. If you check two or more boxes, targeted carotid screening is clinically appropriate. The Framingham Heart Study (2023 update) data consistently shows that risk factor accumulation is multiplicative, not merely additive - two risk factors together produce a substantially higher absolute risk than either would alone.

• ☐ Age 55 or older Atherosclerosis is a decades-long process. The prevalence of significant carotid plaque rises sharply after age 55 in both men and women. Risk continues to increase with each decade. The National Stroke Association notes that stroke risk roughly doubles every decade after age 55.
• ☐ Hypertension (high blood pressure) Sustained elevated blood pressure damages the endothelial lining of arterial walls, creating the conditions that allow LDL cholesterol to penetrate and initiate plaque formation. Hypertension affects approximately 47% of U.S. adults according to the CDC (2023) and is the single most common modifiable stroke risk factor.
• ☐ Current or former smoker Smoking accelerates atherosclerosis through oxidative stress, endothelial injury, and prothrombotic effects. Former smokers carry elevated risk for years after cessation. Smoking doubles the risk of ischemic stroke compared to non-smokers, per the American Heart Association (2022).
• ☐ Diabetes (Type 1 or Type 2) Chronically elevated blood glucose causes glycation of arterial walls and accelerated plaque formation. People with diabetes have a two- to fourfold higher stroke risk than those without diabetes, according to the American Diabetes Association (2023). Carotid intima-media thickness is measurably increased even in early diabetes.
• ☐ High cholesterol (hyperlipidemia) Elevated LDL cholesterol is the substrate of atherosclerotic plaque. Lipid-rich plaque deposits in the carotid arteries at the bifurcation - the anatomic point where turbulence is greatest and plaque is most prone to rupture. Statins reduce carotid plaque progression; a baseline scan documents whether treatment is working.
• ☐ Prior TIA or mini-stroke A transient ischemic attack is a medical emergency, not just a warning sign to monitor. The risk of a full stroke within 90 days of a TIA is as high as 10-15%, with the highest risk in the first 48 hours, per the AHA/ASA (2021). If you've had a TIA, carotid imaging is not optional - it is urgent.
• ☐ Peripheral artery disease (PAD) Atherosclerosis is a systemic disease. If you have plaque narrowing the arteries in your legs, you very likely have it elsewhere. PAD is a strong predictor of carotid and coronary atherosclerosis. Patients with confirmed PAD have roughly a 3-fold higher risk of stroke compared to age-matched controls, per the Journal of the American Heart Association (2022).
• ☐ Family history of stroke or early cardiovascular disease Having a first-degree relative who had a stroke or heart attack before age 65 raises your own risk through shared genetic predispositions to hypertension, dyslipidemia, and vascular inflammation. Family history compounds the effect of any other risk factors you carry. It should always be factored into the screening decision.

What Does a Carotid Duplex Actually Measure?

A carotid duplex uses two imaging modes simultaneously, which is where the word "duplex" comes from. B-mode ultrasound produces the grey-scale anatomical image. Doppler measures blood flow velocity. Together they give a complete picture of both structure and function - something no single-mode test provides. The exam focuses primarily on the carotid bifurcation, where the common carotid artery splits into the internal and external branches, because that's where turbulent flow concentrates plaque.

Intima-media thickness (IMT). The intima and media are the two innermost layers of the arterial wall. Increased IMT is an early marker of atherosclerosis, detectable before any plaque is visible. The American College of Cardiology (ACC, 2021) notes that IMT measurement can be used to refine cardiovascular risk assessment in intermediate-risk patients. An elevated IMT without discrete plaque tells us the process has started.

Plaque characterization. B-mode imaging visualizes plaque directly. We can see how large it is, where it's located, and something about its composition. Soft, heterogeneous plaque is more vulnerable to rupture than calcified, homogeneous plaque. A plaque that ruptures is what causes emboli to travel to the brain. Size matters - but so does composition.

Peak systolic velocity (PSV) and end-diastolic velocity (EDV). As a stenosis narrows the arterial lumen, blood accelerates to maintain flow - much like water speeds up through a narrowed garden hose. We measure peak systolic velocity and end-diastolic velocity using pulsed-wave and continuous-wave Doppler. These velocity criteria, established by the Society of Radiologists in Ultrasound (SRU, 2003; updated 2011), are the primary method for grading stenosis severity. An ICA PSV above 125 cm/s signals at least 50% stenosis; above 230 cm/s signals 70% or greater stenosis.

ICA/CCA ratio. The ratio of internal carotid artery velocity to common carotid artery velocity provides a secondary grading parameter that helps confirm borderline cases. We use multiple criteria together, not just a single number, because no one measurement is perfectly sensitive on its own.

Why Detecting Carotid Disease Before Symptoms Matters

Stroke is, with rare exceptions, not something you feel coming. The CDC (2023) estimates that up to 80% of strokes are preventable with appropriate risk factor management and timely intervention. But that prevention window only exists if you know disease is present. Carotid plaque that hasn't caused a symptom yet is still dangerous. Plaque rupture or embolization can occur before stenosis reaches a surgical threshold, which means waiting for symptoms is not a safe default strategy.

The clinical benefit of knowing about asymptomatic carotid disease operates through two channels. First, it confirms and motivates aggressive medical management: statin therapy, blood pressure control, antiplatelet agents, and lifestyle modification. Evidence from the ACST-2 trial (Lancet, 2021) shows that intensive medical therapy substantially reduces stroke risk in asymptomatic carotid stenosis, comparable to surgical intervention in many patients. You can't optimize the therapy if you don't know the disease is there.

Second, for the subset with severe stenosis (70% or greater), the finding enables a timely surgical discussion with a vascular surgeon. Knowing your warning signs matters too - but warning signs by definition come after the disease is advanced. Imaging is the only tool that finds the disease before it announces itself.

What Do Carotid Ultrasound Results Actually Mean?

The board-certified cardiologist report you receive after your carotid duplex uses standardized language. Here's what each category means clinically and what typically follows from each finding.

Normal. No plaque. Normal flow velocities. No hemodynamically significant stenosis. The intima-media thickness is within normal limits for age. This result is genuinely reassuring. It does not mean you can ignore risk factors, but it confirms that the disease process has not yet produced structural changes. Rescreening is appropriate in 3-5 years depending on your risk profile.

Mild plaque, less than 50% stenosis. Discrete plaque is present but does not create hemodynamically significant flow restriction. This is a common finding in adults over 60 with cardiovascular risk factors. It confirms atherosclerosis is active. It does not by itself indicate surgical need, but it does warrant aggressive risk factor management and serial surveillance. Typically rescreened every one to two years.

Moderate stenosis, 50-69%. Blood flow is measurably restricted. Velocity criteria confirm significant narrowing. At this level, the vessel can still compensate, but plaque rupture risk increases. Cardiology or vascular surgery referral is appropriate. Most patients with moderate stenosis are managed medically with close surveillance - typically every 6-12 months - and surgical discussion reserved for progression or symptom development.

Severe stenosis, 70% or greater. This finding requires prompt vascular surgery or neurology referral. The NASCET trial established that symptomatic patients with severe stenosis have a dramatically reduced stroke risk with carotid endarterectomy compared to medical management alone. In asymptomatic patients, the benefit calculation is more nuanced and depends on the patient's overall surgical risk and the center's procedural complication rate - but finding 70%+ stenosis always changes the management conversation.

How Often Should You Rescreen After a Baseline?

Rescreening intervals are not arbitrary. They're based on the known progression rate of carotid stenosis and the velocity thresholds that trigger clinical action. The Society for Vascular Surgery (SVS, 2022) provides surveillance guidance tied directly to baseline stenosis severity. The goal is catching progression before it crosses a clinically significant threshold - not finding out about it after symptoms occur.

Normal baseline. With no plaque and well-controlled risk factors, rescreening every 3-5 years is generally appropriate. If a new risk factor develops - a new diabetes diagnosis, for example, or a significant change in blood pressure - rescreening sooner makes clinical sense.

Mild plaque, under 50% stenosis. Annual or every 1-2 year surveillance is standard. The goal is detecting acceleration of stenosis before it reaches 50% and the clinical conversation changes. Consistent surveillance also documents whether risk factor management is stabilizing or reversing plaque progression.

Moderate stenosis, 50-69%. Every 6-12 months. At this level, the rate of progression matters urgently. An increase to 70% changes the surgical calculus. Six-month intervals allow timely detection of acceleration without overtesting.

Severe stenosis, 70% or greater. This is no longer a surveillance situation - it requires immediate vascular surgery or neurology referral. The sonographer's job at that point is to provide the best possible velocity data for the surgical team. The scan interval after surgical intervention follows its own protocol.

Frequently Asked Questions